Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1675
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17919008 | ANTIVIRAL STRUCTURALLY-STABILIZED ACE2 HELIX 1 PEPTIDES AND USES THEREOF | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17473362 | METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5 | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17736946 | HIGH CONCENTRATION CELL PENETRATING CASPASE INHIBITOR CONJUGATES, COMPOSITIONS AND METHODS THEREOF | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 17441188 | GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS | Non-Final OA | The Johns Hopkins University |
| 17783704 | USE OF THE GDF-5 MUTANT FOR THE TREATMENT OF PAIN AND CARTILAGE DESTRUCTION | Final Rejection | Merck Patent GmbH |
| 18269134 | COMBINATION THERAPY OF INSULINOTROPIC PEPTIDE AND GLP-2, FOR PREVENTING OR TREATING SHORT BOWEL SYNDROME | Non-Final OA | HANMI PHARM. CO., LTD. |
| 16106348 | Composition and Nutritional Supplement Made Therefrom | Non-Final OA | Lonza Greenwood LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy